Page 100 - Lin News Today

U.N. agencies and aid workers prepositioned tons of dry food and dozens of ambulances with mobile medical teams in sprawling refugee camps in Bangladesh.

Genomic studies of cancer patients have revealed thousands of mutations linked to tumor development.

Linde (NYSE:LIN – Get Rating) had its price objective raised by HSBC from $380.00 to $416.00 in a research note published on Monday, The Fly reports. LIN has been the subject of several other research reports. Wells Fargo & Company raised their price objective on shares of Linde from $350.00 to $375.00 and gave the […]

EverSource Wealth Advisors LLC decreased its stake in shares of Linde plc (NYSE:LIN – Get Rating) by 25.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,099 shares of the basic materials company’s stock after selling 713 shares during the period. […]

Belpointe Asset Management LLC reduced its holdings in Linde plc (NYSE:LIN – Get Rating) by 3.3% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,448 shares of the basic materials company’s stock after selling 83 shares during the quarter. Belpointe Asset Management LLC’s […]

Dorsey & Whitney Trust CO LLC trimmed its position in shares of Linde plc (NYSE:LIN – Get Rating) by 2.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,142 shares of the basic materials company’s stock after selling […]

Linde plc (ETR:LIN – Get Rating) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of €315.44 ($346.64) and traded as high as €333.60 ($366.59). Linde shares last traded at €333.50 ($366.48), with a volume of 17,077 shares trading hands. Wall Street Analyst Weigh In […]

Linde (NYSE:LIN – Get Rating) had its target price upped by HSBC from $380.00 to $416.00 in a research report report published on Monday morning, The Fly reports. A number of other analysts also recently commented on LIN. Mizuho upped their price objective on Linde from $370.00 to $382.00 in a report on Friday, April […]

In an advance that could help scientists learn more about cancer-linked mutations whose roles are not known, MIT researchers have developed a way to easily engineer specific cancer-linked mutations into mouse models, using CRISPR prime editing.

Obermeyer Wood Investment Counsel Lllp cut its stake in shares of Linde plc (NYSE:LIN – Get Rating) by 5.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 930 shares of the basic materials company’s stock after selling 52 shares during […]